Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2016

View Archived Issues

NeuroVive Pharmaceutical announces partial acquisition of Isomerase Therapeutics

FDA awards orphan drug designation to N-91115 for cystic fibrosis

Grant supports Evestra's research into long-acting injectable fertility control

MediciNova's ibudilast receives FDA rare pediatric disease designation for Krabbe disease

Interim report from phase I trial of Blautix for IBS

CRISPR-mediated Dmd editing shows promise for the treatment of DMD

Biological immunomodulator displays bi-phasic treatment response in preclinical HBV infection model

Centauri acquires Alphamer immuno-therapeutics platform technology from Altermune

Acorda Therapeutics agrees to acquire Biotie Therapies

Shanghai Hengrui Pharmaceutical presents hURAT1 inhibitor

Incyte patents KDM1A inhibitors

Pierre Fabre discloses anticancer flavagline derivatives

Novartis reports sGC activators

Daewoong Pharmaceutical describes EPRS inhibitors

Maruho and Galderma establish strategic alliance in Japan

TocopheRx divulges FSH-R agonists

FDA expands age indication for GSK's Hiberix

Janssen suspends phase II clinical trials of FAAH inhibitor

GlycoMar and MicroA establish joint venture business Prasinotech

Gene variants in AD risk genes are associated with brain amyloidosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...